Aion Therapeutic Inc.
ANTCF
$0.012
-$0.003-20.00%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.94% | 60.97% | -130.43% | 58.20% | 68.85% |
| Total Depreciation and Amortization | 158.14% | -- | -- | -92.31% | -68.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.57% | -94.23% | 102.69% | -41.53% | -476.34% |
| Change in Net Operating Assets | 202.34% | -18.89% | -67.46% | -63.85% | -66.13% |
| Cash from Operations | 302.70% | -1,815.00% | -65.93% | 1,116.30% | -14.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -117.25% | -- | -- | -100.00% | 902.40% |
| Total Debt Issued | 90.22% | -- | -- | -98.60% | -83.66% |
| Total Debt Repaid | 91.39% | -- | -- | -- | -796.84% |
| Issuance of Common Stock | -- | 171.30% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 139.45% | 53.73% | 131.81% | -98.94% | -219.76% |
| Foreign Exchange rate Adjustments | -15.57% | 100.94% | 111.30% | -67.36% | 1,286.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,680.00% | 107.69% | -98.48% | 113.33% | -44.93% |
